SenesTech, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the three and nine months ended September 30, 2026, disclosing increased revenues alongside a wider net loss compared to the prior-year period.

Key Highlights

  • Revenue growth: Net revenues for Q3 2026 were $1,097 thousand, up from $690 thousand in Q3 2025, according to the filing.
  • Wider net loss: The company reported a net loss of $1,956 thousand for the three months ended September 30, 2026, compared to $1,298 thousand in the same period of 2025.
  • Nine-month loss: For the nine months ended September 30, 2026, the net loss totaled $5,851 thousand, versus $4,579 thousand for the same period in 2025.
  • Cash position: Cash and cash equivalents stood at $3,951 thousand as of September 30, 2026, down from $7,575 thousand at December 31, 2025.
  • Accumulated deficit: The accumulated deficit reached $148,331 thousand as of September 30, 2026, compared to $142,480 thousand at year-end 2025.
  • Shares outstanding: As of November 12, 2026, there were 6,823,881 shares of common stock outstanding.
  • Operating expenses surge: Total operating expenses for Q3 2026 were $2,787 thousand, up from $1,780 thousand in Q3 2025, driven largely by sales and marketing costs rising to $1,082 thousand from $425 thousand.

SenesTech Reports Higher Q3 2026 Sales Alongside Increased Operating Costs

According to the filing, SenesTech (NASDAQ:SNES) reported net revenues of $1,097 thousand for the three months ended September 30, 2026, an increase from $690 thousand in the same quarter of 2025. Gross profit for Q3 2026 was $796 thousand, compared to $433 thousand a year earlier. For the nine-month period, net revenues totaled $2,360 thousand versus $1,800 thousand in the first nine months of 2025, with gross profit of $1,701 thousand compared to $1,155 thousand.

The company disclosed that total operating expenses for Q3 2026 rose to $2,787 thousand from $1,780 thousand in Q3 2025. Sales and marketing expenses more than doubled to $1,082 thousand from $425 thousand, while general and administrative expenses increased to $1,287 thousand from $955 thousand. Research and development costs were $418 thousand in Q3 2026 versus $400 thousand in Q3 2025. The resulting loss from operations for Q3 2026 was $1,991 thousand, compared to $1,347 thousand in the year-ago quarter.

The filing reported that net cash used in operating activities for the nine months ended September 30, 2026 was $4,960 thousand, compared to $4,086 thousand for the same period in 2025. Total assets were $8,143 thousand as of September 30, 2026, down from $12,843 thousand at December 31, 2025. Stockholders' equity declined to $4,598 thousand from $9,568 thousand at year-end 2025. The company noted that common shares issued and outstanding were 5,475,428 as of September 30, 2026, up from 5,223,015 at December 31, 2025. Net loss per share - basic and diluted for Q3 2026 was $(0.36), compared to $(0.28) in Q3 2025.

What Was Disclosed

SenesTech filed its Form 10-Q for the quarter ended September 30, 2026, reporting higher revenues and gross profit year over year, offset by a significant rise in operating expenses, resulting in a wider net loss and a reduced cash and total asset position.